Immunosuppression (IST) Can Be Safely Ceased During Chemotherapy For Post-Transplant Lymphoproliferative Disorders (PTLD) In Renal Transplant Patients
Year: 2013
Type: article
Study design: Observational Study
Source: Blood
Institutions: Princess Alexandra Hospital, The University of Queensland
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2534327955
